Researchers at The University of Texas at Austin have identified an antibody, SC27, capable of neutralizing all known variants of SARS-CoV-2 , the virus behind COVID-19, as well as related coronaviruses found in animals. Using advanced technology, the research team isolated SC27 from a patient and determined its molecular structure, paving the way for large-scale production and future treatments. This antibody blocks the virus by targeting its spike protein, preventing it from attaching to and infecting human cells.
SC27's ability to recognize the spike proteins of multiple variants highlights its potential to protect against current and future strains of the virus. As COVID-19 variants continue to evolve, researchers are exploring the possibility of developing a universal vaccine that provides comprehensive protection. The findings come during another rise in COVID-19 cases,…
